About this trial
The project endeavours to investigate the feasibility and acceptability of a psychoeducational training intervention for professional burnout and related psychological variables among both medical and non-medical workers in Ukraine during wartime. A secondary aim is to assess the outcomes of the intervention at baseline (T0), post-intervention (T1), and follow-up (single-arm feasibility design). The participants receive two days of a psychoeducational training focusing on different facets of burnout prevention.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Respondents must be 18 years of age or older.
Sufficient command of the Ukrainian language to understand the materials and complete the questionnaires.
Voluntary informed consent to participate in the study and data processing.
Permanent residence in Ukraine at the time of participation in the study.
Disqualifiers
Inability to provide informed consent or limited legal capacity.
Presence at the time of inclusion of a condition that significantly complicates participation in the study or adherence to the protocol (acute psychotic episodes, manic states, severe cognitive impairment, decompensated somatic diseases, active dependence on psychoactive substances), Severe mental state or pronounced mental distress requiring urgent specialized care.
Current intensive psychotherapeutic or psychiatric treatment that may significantly affect the assessed indicators.
Lack of technical ability to participate in online training or complete questionnaires at specified times.
Trial design
Single group
Treatments tested in this trial
Burnout prevention
BehavioralThe training is practical in nature and aims to build and/or increase motivation to implement effective strategies for preventing burnout syndrome. Participants learn about scientifically proven methods of supporting mental health and receive tools for applying them in their professional and everyday lives. The training program covers, in particular, the following areas: managing working time and workload; effective professional communication; developing stress-resistant thinking patterns; forming healthy lifestyle habits; methods of relaxation and overcoming stressful situations.
Treatment groups
Trial outcomes
Primary outcomes
Acceptability of the intervention
Feasibility will be indexed by participants attendance of the workshop sessions (\>25% of sessions).
Feasibility of intervention
Feasibility will be indexed by drop-out rate (\<50% of participants); dropout is defined as having attended none of the sessions
Acceptability of the intervention
Acceptability will be indexed by the retention rate (having filled out the post-intervention questionnaire) of participants to the study (\>30% of questionnaires).
Acceptability of the intervention
Acceptability will be assessed by using the Client Satisfaction Questionnaire (Attkisson \& Zwick, 1982)
Secondary outcomes
Stress, anxiety and depression
The Depression Anxiety Stress Scale (Nilges \& Essau, 2015) will be used to analyse symptoms of stress, anxiety and depression. The main score ranges from 0 to 63, with higher scores indicating higher levels of depressive and anxiety symptoms.
Resilience
The Brief Resilience Scale (Smith 2009) will be used to assess the ability to bounce back or recover from stress. The scale consists of six items rated on a 5-point Likert scale. For interpretation, a mean score is calculated ranging from 1 to 5, with higher scores indicating greater resilience.
Traumatic stress
The International Trauma Questionnaire (Cloitre 2018) will be used to assess traumatic stress. Scores range from 0 to 25, with higher scores indicating greater somatic symptom burden
Burnout - Exhaustion
The Masslach Burnout Inventory (Masslach et al., 1997) will be used to assess burnout, with the domain of emotional exhaustion ranging from 0-54.
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Charite University, Berlin, Germany
Lead sponsor
Bogomolets National Medical University
Collaborator